Biomarkers identification for PML monitoring, during Natalizumab (Tysabri®) treatment in Relapsing-Remitting Multiple Sclerosis
Autor: | Lanza Cariccio, Veronica, Bramanti, Placido, Mazzon, Emanuela |
---|---|
Zdroj: | In Multiple Sclerosis and Related Disorders February 2018 20:93-99 |
Databáze: | ScienceDirect |
Externí odkaz: |